Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Main Authors: | Liam F. Spurr, Sean P. Pitroda |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-023-00492-8 |
Similar Items
-
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
by: Boyu Sun, et al.
Published: (2023-12-01) -
A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
by: Hongen Kang, et al.
Published: (2023-08-01) -
New approaches to treating cancer using immune-checkpoint blockade
by: Fellermeyer, M
Published: (2023) -
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
by: Hao Nie, et al.
Published: (2024-04-01) -
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
by: Zhaohua Zhu, et al.
Published: (2022-12-01)